







Company Information
Ask for more detail from the seller
Contact SupplierBevacizumab Injection is a crucial medication used in the treatment of various types of cancer. As a reputable Bevacizumab Injection supplier, Vihari Co Exim plays a vital role in ensuring the availability of this life-saving drug. With a focus on quality and reliability, Vihari Co Exim is a trusted name in the pharmaceutical industry.
Abevmy Bevacizumab Injection
Abevmy Bevacizumab Injection is one of the key products offered by Vihari Co Exim. Known for its effectiveness in targeting cancer cells by inhibiting the growth of new blood vessels, Abevmy is widely used in the treatment of colorectal, lung, kidney, and ovarian cancers.
Bevacizumab Injection Supplier
Vihari Co Exim stands out as a leading Bevacizumab Injection supplier, ensuring timely delivery and competitive pricing. With a commitment to maintaining the highest standards of quality, Vihari Co Exim has established itself as a reliable partner for healthcare providers and patients in need of Bevacizumab.
As an exporter, supplier, and trader of pharmaceutical products, Vihari Co Exim has a global reach, serving customers in various countries. The company's dedication to ethical business practices and customer satisfaction sets it apart in the industry.
Bevacizumab injection products are used to treat a variety of solid tumors. This includes certain lung, kidney, liver, brain, colon, rectal, female reproductive organ or peritoneal (tissue that lines the abdomen) cancers. Bevacizumab injection products are in a class of medications called antiangiogenic agents. They work by stopping the formation of blood vessels that bring oxygen and nutrients to tumors. This may slow the growth and spread of tumors.
Bevacizumab injection products come as a solution (liquid) to be slowly injected intravenously (into a vein) by a doctor or nurse in a hospital or medical facility. It is given once every 2 or 3 weeks. The schedule depends on the condition you have, the other medications you are using, and how your body responds to treatment.
It should take 90 minutes for you to receive your first dose of a bevacizumab injection product. A doctor or nurse will watch you closely to see how your body reacts to bevacizumab. If you do not have any serious problems when you receive your first dose of a bevacizumab injection product, it will usually take 30 to 60 minutes for you to receive each of your remaining doses of the medication.
Bevacizumab injection products may cause serious reactions during infusion of the medication. If you experience any of the following symptoms, tell your doctor immediately: difficulty breathing or shortness of breath, chills, shaking, sweating, headaches, chest pain, dizziness, feeling faint, flushing, itching, rash, or hives. Your doctor may need to slow down your infusion, or delay or stop your treatment if you experience these or other side effects.
Bevacizumab injection products are also sometimes used to treat wet age-related macular degeneration (AMD; an ongoing disease of the eye that causes loss of the ability to see straight ahead and may make it more difficult to read, drive, or perform other daily activities) and diabetic macular edema (an eye disease caused by diabetes that can lead to vision loss). Talk to your doctor about the risks of using bevacizumab injection products to treat your condition.
This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.





